| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 46 |
| 1 | MYCOPHENOLATE MOFETIL | 12 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 12 |
| 3 | PREDNISONE | 8 |
| 4 | METHOTREXATE SODIUM | 6 |
| 5 | RAVULIZUMAB | 6 |
| 6 | ACETAMINOPHEN | 4 |
| 7 | ACETAMINOPHEN 500MG | 4 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 4 |
| 9 | CARFILZOMIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CROVALIMAB | 1 | 0.0083 |
| 1 | ECULIZUMAB | 46 | 0.0008 |
| 2 | ISATUXIMAB | 2 | 0.0003 |
| 3 | ALOGLIPTIN | 1 | 0.0003 |
| 4 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 2 | 0.0002 |
| 6 | CHLORPROMAZINE | 1 | 0.0002 |
| 7 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 1 | 0.0001 |
| 8 | CARFILZOMIB | 4 | 0.0001 |
| 9 | BENZTROPINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Complement Inhibitor [EPC] | 52 | 0.0009 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 4 | Alkaloid [EPC] | 3 | 0.0001 |
| 5 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 8 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 9 | Proteasome Inhibitor [EPC] | 4 | 0.0000 |